// App-Quantinova.ai

2165 : Re-Evaluating the Prognosis and Transformation Risk of Chronic Eosinophilic Leukemia

Researchers

Presenter

  • Daniel O'Leary

Principal Investigators

  • Amrita Goyal

Medical Centers

  • University of Minnesota, Minneapolis, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Acute lymphoblastic leukemia

  • Myeloid neoplasms

  • Peripheral T-cell lymphoma

  • Acute myelocytic leukemia

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Burkitt lymphoma

  • Hodgkin's Lymphoma

  • B cell lymphomas

  • T-cell lymphoma

  • Acute Leukemia

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved